Display search results for ** instead (34 products)

Showing 1-10 of 34

This Vital Signs issue discusses the Danaher's acquisition of Cepheid for nearly $4 Billion in cash, and Orphan Drug Expenditures in the United States: A Historical and Prospective Analysis, 2007–2013.

USD 600.00

USD 450.00 save 25 %

USD 500.00

USD 375.00 save 25 %

The race to fulfil the promise of a smart future — be it the benefits of smart mobility, smart energy, or smart cities — has kick-started rich veins of possible inventions. Start-ups jostle with established technologists for technology leadership and mindshare to enrich the necessary architecture for such smart systems, or the Internet of Thing...

USD 500.00

USD 375.00 save 25 %

Frost & Sullivan was invited to attend Fortinet’s 3rd EMEA 361° Security Forum in September and we took the opportunity to ask Mr. Michael Xie, Co-founder, President, and Chief Technology Officer (CTO), a few questions.

USD 500.00

USD 375.00 save 25 %

26 Sep 2016  |  Global

IoT Security: The Impossible Mission

2015 was the year for Internet of Things (IoT) in term of positive perspectives, growth potential, industry impacts, and new revenue sources. Frost & Sullivan revealed that by 2020, the total global market will reach over $200 billion and every household will have at least 10 connected devices. In the coming year, the construction market will emerg...

USD 500.00

USD 375.00 save 25 %

The Brexit vote’s impact on investment into UK technology start-ups is an important litmus test for broader implications for the UK economy. The UK’s technology sector is a huge driver of growth, performing markedly above the broader economy and with rapid job creation.

USD 500.00

USD 375.00 save 25 %

This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.

USD 600.00

USD 450.00 save 25 %

In June, the European Data Forum (EDF) 2016 brought together about 1,000 participants from almost 50 countries in Eindhoven, Netherlands to share and discuss ideas about the importance, proliferation, and uses of data in the global economy and society. Three parallel tracks saw senior and executive leaders deliver more than 40 presentations to a Bi...

USD 500.00

USD 375.00 save 25 %

This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.

USD 450.00

USD 337.50 save 25 %

Showing 1-10 of 34